Bluejay Diagnostics (BJDX) Amortizatization of Intangibles (2020 - 2023)
Bluejay Diagnostics (BJDX) reported Amortizatization of Intangibles of $40327.0 for Q2 2023, up 4.11% on a YoY basis from $38734.0 in Q2 2022, and little changed sequentially from $40328.0 in Q1 2023.
Bluejay Diagnostics (BJDX) Amortizatization of Intangibles (2020 - 2023) Analysis & Trends
Bluejay Diagnostics (BJDX) has 4 years of Amortizatization of Intangibles data on file, last reported at $40327.0 in Q2 2023.
- For the quarter ending Q2 2023, Amortizatization of Intangibles rose 4.11% year-over-year to $40327.0; the trailing twelve-month figure through Jun 2023 stood at $147627.0 (up 363.78% YoY), and the FY2022 full-year result was $145837.0, up 536.87% from the prior year.
- Amortizatization of Intangibles was little changed at $40327.0 in Q2 2023, from $40328.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $40328.0 in Q1 2023 to a low of -$122938.0 in Q4 2021.
- A 4-year average of -$2189.6 and a median of $29167.0 in 2020 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles tumbled 77.7% in 2021 and surged 42.81% in 2023, its largest moves.
- Tracing BJDX's Amortizatization of Intangibles over 4 years: stood at -$69183.0 in 2020, then sank by 77.7% to -$122938.0 in 2021, then jumped by 131.51% to $38734.0 in 2022, then grew by 4.11% to $40327.0 in 2023.
- Business Quant data shows BJDX's Amortizatization of Intangibles at $40327.0 in Q2 2023, $40328.0 in Q1 2023, and $38734.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Bluejay Diagnostics | 1.07 Mn | 1.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 40,327.00 |
| Jun 30, 2023 | 40,327.00 |
| Mar 31, 2023 | 40,328.00 |
| Mar 31, 2023 | 40,328.00 |
| Jun 30, 2022 | 38,734.00 |
| Jun 30, 2022 | 38,734.00 |
| Mar 31, 2022 | 28,238.00 |
| Mar 31, 2022 | 28,238.00 |
| Dec 31, 2021 | -122,938.00 |
| Dec 31, 2021 | -122,938.00 |
| Dec 31, 2020 | -69,183.00 |
| Dec 31, 2020 | -69,183.00 |
| Sep 30, 2020 | 29,167.00 |
| Sep 30, 2020 | 29,167.00 |